Search by Drug Name or NDC

    NDC 65597-0202-07 SAVAYSA 30 mg/1 Details

    SAVAYSA 30 mg/1

    SAVAYSA is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Daiichi Sankyo. The primary component is EDOXABAN TOSYLATE.

    Product Information

    NDC 65597-0202
    Product ID 65597-202_ecdf9b93-99ef-4356-a6cc-15d04a4b28c4
    Associated GPIs 83370030200330
    GCN Sequence Number 073294
    GCN Sequence Number Description edoxaban tosylate TABLET 30 MG ORAL
    HIC3 M9V
    HIC3 Description DIRECT FACTOR XA INHIBITORS
    GCN 37676
    HICL Sequence Number 041672
    HICL Sequence Number Description EDOXABAN TOSYLATE
    Brand/Generic Brand
    Proprietary Name SAVAYSA
    Proprietary Name Suffix n/a
    Non-Proprietary Name EDOXABAN TOSYLATE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 30
    Active Ingredient Units mg/1
    Substance Name EDOXABAN TOSYLATE
    Labeler Name Daiichi Sankyo
    Pharmaceutical Class Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA206316
    Listing Certified Through 2024-12-31

    Package

    NDC 65597-0202-07 (65597020207)

    NDC Package Code 65597-202-07
    Billing NDC 65597020207
    Package 7 TABLET, FILM COATED in 1 BOTTLE (65597-202-07)
    Marketing Start Date 2015-01-31
    NDC Exclude Flag N
    Pricing Information N/A